Pfizer Inc.
PFE
$26.32
$0.060.23%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 12/31/2023 | 10/01/2023 | 07/02/2023 | 04/02/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 58.50B | 68.54B | 77.94B | 92.95B | 100.33B |
| Total Other Revenue | -- | 2.22B | 2.22B | 2.22B | 2.22B |
| Total Revenue | 58.50B | 68.54B | 77.94B | 92.95B | 100.33B |
| Cost of Revenue | 24.10B | 21.36B | 24.09B | 29.33B | 34.55B |
| Gross Profit | 34.40B | 47.18B | 53.85B | 63.62B | 65.79B |
| SG&A Expenses | 13.83B | 13.57B | 13.40B | 13.26B | 12.20B |
| Depreciation & Amortization | 4.73B | 4.60B | 4.24B | 3.88B | 3.61B |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 53.34B | 50.95B | 53.16B | 58.09B | 61.78B |
| Operating Income | 5.15B | 17.59B | 24.78B | 34.86B | 38.55B |
| Income Before Tax | 1.06B | 10.42B | 22.77B | 31.95B | 34.73B |
| Income Tax Expenses | -1.12B | -90.00M | 1.23B | 2.87B | 3.33B |
| Earnings from Continuing Operations | 2.17K | 10.51K | 21.54K | 29.08K | 31.40K |
| Earnings from Discontinued Operations | -15.00M | 13.00M | -20.00M | 16.00M | 6.00M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -39.00M | -38.00M | -47.00M | -42.00M | -35.00M |
| Net Income | 2.12B | 10.48B | 21.47B | 29.05B | 31.37B |
| EBIT | 5.15B | 17.59B | 24.78B | 34.86B | 38.55B |
| EBITDA | 11.41B | 23.69B | 30.50B | 40.18B | 43.58B |
| EPS Basic | 0.38 | 1.86 | 3.82 | 5.18 | 5.60 |
| Normalized Basic EPS | 0.77 | 2.14 | 2.96 | 4.05 | 4.42 |
| EPS Diluted | 0.36 | 1.83 | 3.76 | 5.08 | 5.48 |
| Normalized Diluted EPS | 0.75 | 2.11 | 2.91 | 3.97 | 4.33 |
| Average Basic Shares Outstanding | 22.57B | 22.54B | 22.50B | 22.45B | 22.43B |
| Average Diluted Shares Outstanding | 22.73B | 22.83B | 22.90B | 22.90B | 22.93B |
| Dividend Per Share | 1.64 | 1.63 | 1.62 | 1.61 | 1.60 |
| Payout Ratio | 327.18% | 65.47% | 42.42% | 31.11% | 28.63% |
